Health Care & Life Sciences » Biotechnology | AzurRx BioPharma Inc.

AzurRx BioPharma Inc.

AzurRx BioPharma Inc.
Stock Exchange NASDAQ Stock Market
EPS
$0.86
Market Cap
$30.54 M
Shares Outstanding
21.06 M
Public Float
11.13 M

Profile

Address
760 Parkside Avenue
Brooklyn New York 11226
United States
Employees -
Website http://www.azurrx.com
Updated 07/08/2019
AzurRx BioPharma, Inc. is a development stage company, which engages in the research and development of non-systemic biologics for the treatment of patients with gastrointestinal disorders. It offers MS1819 and AZX1101 that are therapeutic proteins products under development. The company was founded on January 30, 2014 and is headquartered in Brooklyn, NY.

Financials

View All

Maged S. Shenouda
Chief Financial Officer & Non-Executive Director
Edward J. Borkowski
Chairman